Vaishali Pharma Ltd

AI
Vaishali Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Vaishali Pharma Ltd

₹ 6.73 -0.88%
04 Nov - close price
Company website NSE: VAISHALI
About

Incorporated in 1989, Vaishali Pharma Ltd
does marketing of pharmaceutical products including active pharmaceutical ingredients[1]

Key Points

Business Overview:[1]
VPL is certified by ISO 9001:2008 and provides 1500+ products and 250+ brands, including APIs, Formulations, Surgical, Herbals, Veterinary, Nutraceutical, Oncology, and other healthcare products in 35+ locations

Website NSE
  • Market Cap ₹ 90.9 Cr.
  • Current Price ₹ 6.73
  • High / Low ₹ 10.2 / 4.75
  • Stock P/E 20.3
  • Book Value ₹ 5.30
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE 5.83 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Promoter holding is low: 31.6%
  • Earnings include an other income of Rs.3.57 Cr.
  • Company has high debtors of 170 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2025 Dec 2025 Mar 2026 Jun 2026
33.45 24.65 26.93 22.89
32.06 23.09 27.13 21.40
Operating Profit 1.39 1.56 -0.20 1.49
OPM % 4.16% 6.33% -0.74% 6.51%
0.84 0.89 1.26 0.58
Interest 0.40 0.51 0.72 0.20
Depreciation 0.17 0.13 0.16 0.14
Profit before tax 1.66 1.81 0.18 1.73
Tax % 28.31% 28.18% -61.11% 13.87%
1.19 1.32 0.41 1.55
EPS in Rs 0.09 0.10 0.03 0.12
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2026 TTM
109 108
105 104
Operating Profit 4 4
OPM % 3.8% 3.9%
4 4
Interest 2 2
Depreciation 1 1
Profit before tax 5 5
Tax % 25%
4 4
EPS in Rs 0.31 0.34
Dividend Payout % 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: %
5 Years: 14%
3 Years: -21%
1 Year: -33%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2026
Equity Capital 26
Reserves 43
19
35
Total Liabilities 123
2
CWIP 0
Investments 6
116
Total Assets 123

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2026
0
-5
5
Net Cash Flow -0
Free Cash Flow -0
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 22%

Ratios

Consolidated / View Standalone

Mar 2026
Debtor Days 170
Inventory Days 13
Days Payable 81
Cash Conversion Cycle 102
Working Capital Days 212
ROCE %

Insights

In beta
Mar 2017 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Export Revenue (FOB)
Rs. Crores

Log in to view insights

Please log in to see hidden values.

Login
Countries Exported To
count
Formulation Brands Registered
count
Product Registrations Approved
count
Products in Portfolio
count
Customers
count
Product Registrations Applied
count
Distributors (Export)
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
26.62% 26.32% 26.32% 26.32% 26.32% 26.32% 26.32% 26.32% 31.61% 31.61% 31.61% 31.61%
73.38% 73.68% 73.68% 73.67% 73.68% 73.68% 73.68% 73.68% 68.39% 68.39% 68.39% 68.39%
No. of Shareholders 9,1819,3909,47918,98327,54628,87428,68227,75227,14826,53426,67126,702

Documents

Announcements

Annual reports

DRHP

Concalls